Company Valuation: Sernova Biotherapeutics Inc

Data adjusted to current consolidation scope
Fiscal Period: October 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 326.4 234.5 243.9 81.33 59.26 41.54 - -
Change - -28.16% 3.99% -66.65% -27.14% -29.9% - -
Enterprise Value (EV) 326.4 234.5 235.1 75.79 63.76 41.54 41.54 41.54
Change - -28.16% 0.27% -67.77% -15.87% -34.85% 0% 0%
P/E -41.7x -8.89x -5.85x -2.5x -3x -3.67x -2.75x 0.29x
PBR - - 18.4x -6.28x -1.96x -3.67x -2.75x 0.32x
PEG - -0x -0.1x 0.1x 0.1x 0.1x -0.1x -0x
Capitalization / Revenue - - - - - - 8.31x 0.16x
EV / Revenue - - - - - - 8.31x 0.16x
EV / EBITDA - - - - - - - -
EV / EBIT - - - - - - - -
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.03 -0.09 -0.13 -0.1 -0.05 -0.03 -0.04 0.38
Distribution rate - - - - - - - -
Net sales 1 - - - - - - 5 255.6
EBITDA -6.669 -24.31 -40.06 -31.12 -14.68 - - -
EBIT -6.937 -24.75 -40.5 -31.66 -15.02 - - -
Net income 1 -6.966 -24.42 -39 -32.19 -15.74 -12.83 -19.77 172.7
Net Debt - - -8.722 -5.544 4.503 - - -
Reference price 2 1.2500 0.8000 0.7600 0.2500 0.1500 0.1100 0.1100 0.1100
Nbr of stocks (in thousands) 261,133 293,125 320,857 325,325 395,037 377,643 - -
Announcement Date 14/02/22 26/01/23 29/01/24 23/12/24 19/12/25 - - -
1CAD in Million2CAD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-3.67x - - - 30.03M
23.54x4.59x15.78x1.19% 116B
18.1x2.31x8.96x2.83% 12.1B
-219.4x14.89x1768.05x-.--% 10.46B
22.3x10.3x17.84x1.85% 4.2B
24.68x - - - 2.48B
-1463.57x1.74x8.14x-.--% 1.82B
16.73x4.41x8.63x3.66% 1.57B
Average -197.66x 6.37x 304.56x 1.59% 18.62B
Weighted average by Cap. -12.27x 5.27x 140.32x 1.27%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. SVA Stock
  4. Valuation Sernova Biotherapeutics Inc